I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78% Market Closed
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InDex Pharmaceuticals Holding AB
Other Operating Expenses Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Other Operating Expenses
-kr87.9m
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Other Operating Expenses
kr22.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Other Operating Expenses
-kr813k
CAGR 3-Years
83%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Other Operating Expenses
-kr245m
CAGR 3-Years
-43%
CAGR 5-Years
-62%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Other Operating Expenses
-kr633k
CAGR 3-Years
N/A
CAGR 5-Years
59%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Other Operating Expenses
kr1.1m
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Other Operating Expenses?
Other Operating Expenses
-87.9m SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Other Operating Expenses amounts to -87.9m SEK.

What is InDex Pharmaceuticals Holding AB's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
-7%

Over the last year, the Other Operating Expenses growth was -111%. The average annual Other Operating Expenses growth rates for InDex Pharmaceuticals Holding AB have been -16% over the past three years , -7% over the past five years .

Back to Top